Page last updated: 2024-10-20

pyrazinamide and Chronic Hepatitis C

pyrazinamide has been researched along with Chronic Hepatitis C in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research Excerpts

ExcerptRelevanceReference
"Acquired ichthyosis is an uncommon disease usually associated with different systemic diseases."1.33[Acquired ichthyosis revealing hepatic and lymph node tuberculosis]. ( Berady, S; Chaari, J; Ennibi, K; Rabhi, M; Toloune, F, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saitou, Y1
Hatazi, O1
Aonuma, H1
Ogura, S1
Yamamoto, N1
Kobayashi, T1
Rabhi, M1
Ennibi, K1
Berady, S1
Chaari, J1
Toloune, F1

Other Studies

2 other studies available for pyrazinamide and Chronic Hepatitis C

ArticleYear
Pulmonary tuberculoma in a patient with chronic hepatitis C: a clinical pitfall in the treatment strategy.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:15

    Topics: Antitubercular Agents; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up St

2014
[Acquired ichthyosis revealing hepatic and lymph node tuberculosis].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:12 Pt 1

    Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; Drug Therapy, Combination; Follow

2006